InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Oncolution AB. Director active across 1 company, notably AlzeCure Pharma AB. Aggregated, 1 disclosures have been recorded. History available since 30 June 2026. The latest transaction was disclosed on 30 June 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
1 of 1 declaration